Stockreport

Poxel Reports Cash and Revenue for the Full Year 2023 and Provides Corporate Update [Yahoo! Finance]

SUMITOMO CHEM UNSP/ADR  (SOMMY) 
NASDAQ:AMEX Investor Relations: sumitomo-chem.co.jp/english/ir
PDF This growth trajectory is in line to meet or potentially surpass Sumitomo Pharma's FY 2023 forecast The Company remains focused on securing additional financing to exe [Read more]